TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -2 | -1 | -17 | -20 | 2 | -52 | -15 |
| P | %wins | 50 | 50 | 0 | 0 | 50 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/26/07 10:39 | 12/17/07 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Shaaltiel Yoseph | L3 | DO | EVP,R,D | P.m | 50 | 3.38 | 1 | 15 | 1 | 2,974 | D | -92 | -81 | -87 | -92 | -32 | 0 | -7 | -6 | 1 | 7 | -7 | -14 | 13 | -46 |
12/12/07 14:02 | 12/5/07 | PLX | Protalix Biotherapeutics, Inc. | FL | Health | BioPrd | Biological Products, (No Diag | Shaaltiel Yoseph | L3 | DO | EVP,R,D | P | 47 | 3.14 | 1 | 15 | 1 | 2,959 | D | -89 | -85 | -82 | -89 | -28 | -16 | 5 | 1 | -4 | -9 | -27 | -25 | -9 | -58 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |